Rejected at 1:21 a.m. Nov, 01, 2023 ] by dollajas
Author: GroupG_Strep93
Related Note: 1514737162457
Rationale for change

see amboss

Rejection reason

agree resolved in prior suggestion

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#SketchyPharm::07_Antimicrobials::08_Retired_Lessons::04_Ribavirin,_Sofosbuvir,_Simeprevir_[Retired_Video] #AK_Step1_v12::^Other::^EXPN::BGadd #AK_Step1_v12::#Bootcamp::Microbiology::28_Positive-sense_RNA_Viruses::14_Hepatitis_C_Part_2_(Diagnostics_and_Management) #PANCE::EOR::Family_med #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Other::!AK_UpdateTags::AnKing_Image::MS::HCV_management #AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Step1_v12::#Physeo::09_Pharm::02_Antivirals::10_Hepatitis_C_Therapy #PANCE::GI::hepatic_disorders #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::51_Hepatitis_C_therapy #PANCE::EOR::IM #AK_Other::!AK_UpdateTags::AnKing_Image::Mujeeb::HCV_management #PANCE::EOR::EM #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::07_Other_Antivirals::02_Hepatitis_C_Direct-Acting_Antivirals_(DAAs) #AK_Step1_v12::#OME::PreClinical::Microbiology::Microbiology_3::Viruses::Antiviral_Medications #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Microbiology::HCV_management